← All trials
NCT05248919
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2023
- Primary completion
- Sep 1, 2024
- Completion date
- Dec 31, 2024
- First posted
- Feb 21, 2022
- Last posted
- Sep 7, 2023
- Enrollment
- 318
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LondonLead sponsor
- University of LondonOverall official - principal investigator
- Dow University of Health SciencesCollaborator
- University of BristolCollaborator
- Aga Khan UniversityCollaborator
- University of OxfordCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.